JP2952706B2 - Method for producing 4-quinolone derivative - Google Patents
Method for producing 4-quinolone derivativeInfo
- Publication number
- JP2952706B2 JP2952706B2 JP2289600A JP28960090A JP2952706B2 JP 2952706 B2 JP2952706 B2 JP 2952706B2 JP 2289600 A JP2289600 A JP 2289600A JP 28960090 A JP28960090 A JP 28960090A JP 2952706 B2 JP2952706 B2 JP 2952706B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl group
- nmr
- derivative represented
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Catalysts (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Description
【発明の詳細な説明】 産業上の利用分野 本発明は、4−キノロン誘導体の新しい製造方法に関
する。Description: TECHNICAL FIELD The present invention relates to a new method for producing a 4-quinolone derivative.
従来の技術 下記一般式(III)で表される4−キノロン誘導体
は、従来より種々の抗菌剤を合成するための重要中間体
として知られている有用な化合物である。2. Description of the Related Art A 4-quinolone derivative represented by the following general formula (III) is a useful compound conventionally known as an important intermediate for synthesizing various antibacterial agents.
[式中、R1及びR2は、同一又は異なって、水素原子、低
級アルキル基、低級アルケニル基、シクロアルキル基、
水酸基、保護された水酸基、ニトロ基、ハロゲン原子、
シアノ基、アミノ基、エステル基、エステル基の置換し
た低級アルキル基、炭素数1〜4個の直鎖もしくは分枝
鎖状アルキル基が1〜2個置換した低級アルキルアミノ
基、低級アルコキシ基又は置換基を有することのある5
員もしくは6員環の含窒素複数環基を示し、各R1は相互
に異なっていてもよい。] 4−キノロン誘導体の製造法としては、従来次のよう
な方法が知られている。 [Wherein, R 1 and R 2 are the same or different and are each a hydrogen atom, a lower alkyl group, a lower alkenyl group, a cycloalkyl group,
Hydroxyl group, protected hydroxyl group, nitro group, halogen atom,
A cyano group, an amino group, an ester group, a lower alkyl group substituted with an ester group, a lower alkylamino group substituted with one or two linear or branched alkyl groups having 1 to 4 carbon atoms, a lower alkoxy group or 5 which may have a substituent
A 6-membered or 6-membered nitrogen-containing multiple ring group, and each R 1 may be different from each other. As a method for producing a 4-quinolone derivative, the following method is conventionally known.
(1)3−アリ−ルアミノメチリデンマロン酸エステル
類を、高温により熱閉環させる方法[例えばJ.Heterocy
clic Chem.,21,1857(1984)参照]。(1) A method in which 3-arylaminomethylidenemalonates are thermally closed at high temperatures [for example, J. Heterocy]
clic Chem., 21, 1857 (1984)].
(2)3−(2−ハロアリール)−3−ケト−2−アミ
ノメチリデンプロピオン酸エステル類の分子内置換反応
を用いる環形成による方法例えばJ.Med.Chem.,28,1558
(1985)参照]。(2) A method of forming a ring using an intramolecular substitution reaction of 3- (2-haloaryl) -3-keto-2-aminomethylidenepropionates, for example, J. Med. Chem., 28, 1558.
(1985)].
しかしながら、上記(1)の方法では、一般に200℃
以上の高温を要し、熱的に不安定な官能基を有する化合
物には適用されない。他の方法では、効果な試薬を化学
量論量使用する必要があり、工業的に実施するには問題
がある。However, in the above method (1), generally, 200 ° C.
The above-mentioned high temperature is required and it is not applied to a compound having a thermally unstable functional group. Other methods require stoichiometric use of effective reagents, which is problematic for industrial practice.
発明が解決しようとする問題点 本発明の目的は、上記従来法のごとき難点がなく、安
全かつ簡便は操作で、かつ工業的に有利な方法で、しか
も高収率、高純度で一般式(III)で表されるキノロン
カルボン酸誘導体を製造し得る方法を提供することにあ
る。Problems to be Solved by the Invention It is an object of the present invention to provide a method which is free from the drawbacks of the above-mentioned conventional method, is safe and simple in operation, is industrially advantageous, and has a high yield and a high purity by the general formula ( Another object of the present invention is to provide a method capable of producing the quinolone carboxylic acid derivative represented by III).
問題点を解決するための手段 本発明者らは、上記従来法の問題点を解決すべく、鋭
意検討を重ねた結果、パラジウム触媒を用いるカルボニ
ル化法が本発明の目的に適した優れた製造法になり得る
ことを見い出した。Means for Solving the Problems The present inventors have conducted intensive studies in order to solve the problems of the above-mentioned conventional methods. As a result, the carbonylation method using a palladium catalyst is an excellent production method suitable for the purpose of the present invention. I found that it could be a law.
即ち、本発明によれば、一般式(III)で表される4
−キノロン誘導体は、一般式(I)で表されるアニリン
誘導体をカルボニル化することにより、簡便な操作で、
しかも高収率かつ高純度で製造され得る。That is, according to the present invention, 4 represented by the general formula (III)
-The quinolone derivative can be obtained by a simple operation by carbonylating the aniline derivative represented by the general formula (I),
Moreover, it can be produced with high yield and high purity.
本明細書において、低級アルキル基としては、メチル
基、エチル基、プロピル基、ブチル基、イソブチル異、
三級−ブチル基、ペンチル基、ネオベンチル基等を例示
できる。シクロアルキル基としては、シクロプロピル
基、シクロブチル基、シクロペンチル基、シクロヘキシ
ル基等を例示できる。水酸基の保護基としては、プロテ
クティブグループ イン オーガニック シンセシス
(Prctective Groups in Organic Synthesis、Thedora
W.Greene著、以下単に文献という)の第2章(第10〜72
頁)に記載されている各種の基を例示できる。ハロゲン
原子としては、弗素原子、塩素原子、臭素原子、沃素原
子を例示できる。炭素数1〜4個の直鎖もしくは分枝鎖
状アルキル基が1〜2個置換した低級アルキルアミノ基
としては、メチルアミノ基、エチルアミノ基、ジエチル
アミノ基、プロピルアミノ基、ジプロピルアミノ基、三
級−ブチルアミノ基、ジ−三級−ブチルアミノ基、三級
−ブチルエチルアミノ基等を例示できる。5員もしくは
6員環の含窒素複素環基としては、 等の基本骨格を有し、環窒素原子又は炭素原子上で結合
している基を例示できる。上記含窒素複素環基における
置換基としては、ハロゲン原子、水酸基、低級アルコキ
シ基、(例えばメトキシ基エトキシ基、プロポキシ基、
イソプロポキシ基、ブトキシ基、イソブトキシ基、三級
−ブトキシ基等)、ニトロ基、シアノ基、アミノ基、炭
素数1〜4個の直鎖もしくは分枝鎖状アルキル基が1〜
2個置換した低級アルキルアミノ基(具体的にはメチル
アミノ、エチルアミノ、ジエチルアミノ、プロピルアミ
ノ、ジプロピルアミノ、三級−ブチルアミノ、ジ−三級
−ブチルアミノ、三級−ブチルエチルアミノ基等)、炭
素数1〜4個の直鎖もしくは分枝鎖状アルキル基が1〜
3個置換した低級アルキルアンモニウム塩(具体的に
は、トリメチルアンモニウム、トリエチルアンモニウ
ム、メチルジエチルアンモニウム、トリイソブチルアン
モニウム、トリ−三級−ブチルアンモニウム等)、アシ
ル基(具体的には、ホルミル、アセチル、プロピオニ
ル、ブチリル、イソブチリル、ピバロイル、ベンゾイ
ル、パラ−メチルベンゾイル、パラ−メトキシベンゾイ
ル、パラ−クロロベンゾイル、パラ−ニトロベンゾイル
基等)アシルオキシ基(具体的には、ホルミルオキシ、
アセチルオキシ、プロピオニルオキシ、ブチリルオキ
シ、イソブチリルオキシ、ピバロイルオキシ、ベンゾイ
ルオキシ、パラ−メチルベンゾイルオキシ、パラ−メト
キシベンゾイルオキシ、パラ−クロロベンゾイルオキ
シ、パラ−ニトロベンゾイルオキシ基等)を例示でき
る。これらの置換基は、上記複素環上に1〜5個置換し
ていてもよい。In the present specification, as the lower alkyl group, a methyl group, an ethyl group, a propyl group, a butyl group, an isobutyl group,
Examples thereof include a tertiary-butyl group, a pentyl group, and a neobentyl group. Examples of the cycloalkyl group include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, and a cyclohexyl group. Hydroxyl-protecting groups include: Protective Groups in Organic Synthesis, Thedora
Chapter 2 (10-72) of W. Greene
Page)). Examples of the halogen atom include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom. Examples of the lower alkylamino group in which one or two linear or branched alkyl groups having 1 to 4 carbon atoms are substituted include a methylamino group, an ethylamino group, a diethylamino group, a propylamino group, a dipropylamino group, Examples thereof include a tertiary-butylamino group, a di-tertiary-butylamino group, and a tertiary-butylethylamino group. As the 5- or 6-membered nitrogen-containing heterocyclic group, And the like, and a group bonded on a ring nitrogen atom or a carbon atom. As the substituent in the nitrogen-containing heterocyclic group, a halogen atom, a hydroxyl group, a lower alkoxy group, (for example, a methoxy group ethoxy group, a propoxy group,
Isopropoxy group, butoxy group, isobutoxy group, tertiary-butoxy group, etc.), nitro group, cyano group, amino group, and linear or branched alkyl group having 1 to 4 carbon atoms.
Two substituted lower alkylamino groups (specifically, methylamino, ethylamino, diethylamino, propylamino, dipropylamino, tertiary-butylamino, di-tertiary-butylamino, tertiary-butylethylamino, etc. ), Wherein the linear or branched alkyl group having 1 to 4 carbon atoms is 1 to
Three substituted lower alkylammonium salts (specifically, trimethylammonium, triethylammonium, methyldiethylammonium, triisobutylammonium, tri-tert-butylammonium, etc.), an acyl group (specifically, formyl, acetyl, Propionyl, butyryl, isobutyryl, pivaloyl, benzoyl, para-methylbenzoyl, para-methoxybenzoyl, para-chlorobenzoyl, para-nitrobenzoyl group, etc.) acyloxy group (specifically, formyloxy,
Acetyloxy, propionyloxy, butyryloxy, isobutyryloxy, pivaloyloxy, benzoyloxy, para-methylbenzoyloxy, para-methoxybenzoyloxy, para-chlorobenzoyloxy, para-nitrobenzoyloxy and the like. These substituents may have 1 to 5 substituents on the heterocyclic ring.
本発明においては、上記一般式(I)で表されるアニ
リン誘導体を上記一般式(II)で表されるアセチレン誘
導体の存在下、パラジウム触媒、一酸化炭素を用いてカ
ルボニル化する。In the present invention, the aniline derivative represented by the general formula (I) is carbonylated using a palladium catalyst and carbon monoxide in the presence of the acetylene derivative represented by the general formula (II).
本発明で用いられるパラジウム触媒としては、特に限
定されるものではなく、2価でも0価でもよく単体でも
錯体の形でも用いられる。これらのパラジウム触媒は、
塩の形でもよく、また適当な配位子と組み合わせても用
いられる。塩としては、塩素化物、臭素化物、沃素化
物、酢酸塩、硫酸塩、過塩素酸塩、アセチルアセトン塩
又はそれらのホスフィン錯体を例示できる。0価錯体と
しては、テトラキストリフェニルホスフィンパラジウ
ム、ビス(ジベンジリデンアセトン)パラジウム、トリ
ス(ジベンジリデンアセトン)ジパラジウム、ビス(ジ
ベンジリデンアセトン)パラジウムクロロホルム、トリ
ス(ジベンジリデンアセトン)ジパラジウムクロロホル
ム、トリス(トリベンジリデンアセチルアセトン)ジパ
ラジウム、トリス(トリベンジリデンアセチルアセウト
ン)ジパラジウムクロロホルム等が例示できる。本発明
においてパラジウム触媒の量は、特に限定されるもので
はなく、0.001〜50モル%の範囲内でっ適宜用いられる
が、好ましくは、0.1〜10モル%の範囲で用いるのがよ
い。2価錯体、0価錯体と共に用いられる配位子として
は、通常のトリフェニルハスフィン、トリ(o−トリ
ル)ホスフィン、トリ(p−トリル)ホスフィン、トリ
(p−メトキシフェニル)ホスフィン等の1座配位子、
1,2−ビス−ジフェニルホスフィノエタン、1,3−ビス−
ジフェニルホスフィノプロパン、1,4−ビス−ジフェニ
ルホスフィノブタン、ジフェニルホスフィノフェロセン
等の2座配位子等のホスフィン類、トリメチルホスファ
イト、トリエチルホスファイト、トリイソプロピルホス
ファイト、トリフェニルホスファイト等のホスファイト
配位子が例示できる。配位子の量は、触媒を安定化させ
る量でよく、通常触媒に対して、1等量から10等量用い
られる。また、触媒は、担持させたものでもよく、水素
添加触媒としてよく知られている5%−パラジウム/炭
素、10%−パラジウム/炭素等も用いられる。また、該
反応は塩基を存在させると反応が速やかに進行する。塩
基としては、エチルアミン、ジエチルアミン、トリエチ
ルアミン、ピリジン等の有機塩基、炭酸カリウム、炭酸
ナトリウム等の無機塩、酢酸カリウム、酢酸ナトリウム
等を酢酸塩が用いられる。斯かる塩基の量は、系中で生
成する酸を中和すればよく、1等量から5等量の範囲で
用いられる。溶媒は、必ずしも必要ではないが、撹拌効
率の面からは、適当量用いたほうがよい。溶媒の使用量
は、特に限定されるものではなく、反応条件等において
適宜検定される。溶媒としては、原料のエナミン誘導体
を溶解するものが好ましい。斯かる溶媒の具体例として
は、テトラハイドロフラン、ジメチルホルムアミド、ア
セトニトリル、ジメチルスルホキシド、ベンゼン、トル
エン等や、これらの混合溶媒を例示できる該反応は、一
酸化炭素雰囲気下で行なわれるが、その圧力は、1〜20
0kg/cm2の範囲で行なわれ、特に好ましくは、1〜70kg/
cm2で実施される。The palladium catalyst used in the present invention is not particularly limited, and may be divalent or zero-valent, and may be used alone or in the form of a complex. These palladium catalysts
It may be in the form of a salt or used in combination with a suitable ligand. Examples of the salt include chlorinated products, brominated products, iodides, acetates, sulfates, perchlorates, acetylacetone salts and phosphine complexes thereof. Examples of the zero-valent complex include tetrakistriphenylphosphine palladium, bis (dibenzylideneacetone) palladium, tris (dibenzylideneacetone) dipalladium, bis (dibenzylideneacetone) palladium chloroform, tris (dibenzylideneacetone) dipalladium chloroform, and tris ( Examples thereof include tribenzylideneacetylacetone) dipalladium and tris (tribenzylideneacetylaceton) dipalladium chloroform. In the present invention, the amount of the palladium catalyst is not particularly limited, and is appropriately used within a range of 0.001 to 50 mol%, but is preferably used within a range of 0.1 to 10 mol%. Examples of the ligand used together with the divalent complex and the zero-valent complex include ordinary triphenyl phosphine, tri (o-tolyl) phosphine, tri (p-tolyl) phosphine, tri (p-methoxyphenyl) phosphine and the like. Coordination ligand,
1,2-bis-diphenylphosphinoethane, 1,3-bis-
Phosphines such as bidentate ligands such as diphenylphosphinopropane, 1,4-bis-diphenylphosphinobutan, and diphenylphosphinoferrocene; trimethylphosphite, triethylphosphite, triisopropylphosphite, triphenylphosphite, and the like Can be exemplified. The amount of the ligand may be an amount that stabilizes the catalyst, and is usually used in an amount of 1 to 10 equivalents to the catalyst. The catalyst may be a supported one, and 5% -palladium / carbon, 10% -palladium / carbon, etc., which are well known as hydrogenation catalysts, may be used. The reaction proceeds quickly when a base is present. Examples of the base include organic bases such as ethylamine, diethylamine, triethylamine, and pyridine; inorganic salts such as potassium carbonate and sodium carbonate; and acetates such as potassium acetate and sodium acetate. The amount of such a base may be used in the range of 1 to 5 equivalents as long as the acid generated in the system is neutralized. The solvent is not always necessary, but it is better to use an appropriate amount from the viewpoint of stirring efficiency. The amount of the solvent to be used is not particularly limited, and is appropriately determined under reaction conditions and the like. As the solvent, those capable of dissolving the raw material enamine derivative are preferable. Specific examples of such a solvent include tetrahydrofuran, dimethylformamide, acetonitrile, dimethylsulfoxide, benzene, toluene, and the like, and the reaction, which may be a mixed solvent thereof, is performed under a carbon monoxide atmosphere. Is 1-20
0 kg / cm 2 , particularly preferably 1 to 70 kg / cm 2
It is carried out in cm 2.
溶媒中の反応試料の濃度は、特に限定されるものでは
ないが、反応効率の面からは、濃度は高い方が好まし
い。反応温度は、通常0〜200℃の範囲で行なわれ、好
ましくは50〜150℃の範囲とするとがよい。また反応時
間は、反応原料濃度、一酸化炭素圧、触媒濃度その他の
反応条件に応じて、適宜選択される。The concentration of the reaction sample in the solvent is not particularly limited, but a higher concentration is preferable from the viewpoint of reaction efficiency. The reaction temperature is usually in the range of 0 to 200 ° C, and preferably in the range of 50 to 150 ° C. The reaction time is appropriately selected according to the reaction raw material concentration, carbon monoxide pressure, catalyst concentration and other reaction conditions.
発明の効果 本発明によれば、上記一般式(III)で表される4−
キノロン誘導体を、特別な精製操作を施すことなく、高
純度、高収率で製造し得る。Effect of the Invention According to the present invention, 4-
A quinolone derivative can be produced in high purity and high yield without performing a special purification operation.
実 施 例 以下に実施例を掲げて、本発明を更に具体的に説明す
るが、本発明は、その要旨を超えない限り、以下の実施
例によって限定されうものではない。EXAMPLES Hereinafter, the present invention will be described more specifically with reference to Examples, but the present invention is not limited to the following Examples as long as the gist is not exceeded.
実施例1 化合物(I a)(213mg,0.97ミリモル),化合物(II
a)(0.2ml,1.82ミリモル)及びジクロロビストリフェ
ニルホスフィンパラジウム36,2mg,0.05ミリモル)のジ
エチルアミン(3ミリリットル)溶液を一酸化炭素加圧
(20kg/cm2)下120℃で6時間反応させる。濃縮後、塩
化メチレンを加え、水洗する。有機層は、乾燥(硫酸ナ
トリウム)し、濃縮した後カラムクロマトグラフィーで
精製すると化合物(III a)(193mg,90%)が得られ
る。Example 1 Compound (Ia) (213 mg, 0.97 mmol), Compound (II
a) A solution of (0.2 ml, 1.82 mmol) and dichlorobistriphenylphosphine palladium (36, 2 mg, 0.05 mmol) in diethylamine (3 ml) is reacted at 120 ° C. for 6 hours under carbon monoxide pressure (20 kg / cm 2 ). After concentration, methylene chloride is added and washed with water. The organic layer is dried (sodium sulfate), concentrated and purified by column chromatography to obtain compound (IIIa) (193 mg, 90%).
IR(KBr); 3460,1636,1599,1584,1549,1506cm-1 1 H−NMR(メタノール−d4)δppm; 6.58(s,1H) 7.40−7.82(m,8H) 8.29(d,J=7.90Hz,1H)13 C−NMR; 108.48,119.71,125.40 125.75,125.97.128.55(2C),130.29(2C), 131.93,133.70,135.46,141.95,153.57,180.64 上記と同様にして得られた結果を以下の表1に示す。
またそれぞのスペクトルデータをまとめて示す。 IR (KBr); 3460,1636,1599,1584,1549,1506cm -1 1 H-NMR ( methanol -d 4) δppm; 6.58 (s , 1H) 7.40-7.82 (m, 8H) 8.29 (d, J = 7.90 Hz, 1 H) 13 C-NMR; 108.48, 119.71, 125.40 125.75, 125.97.128.55 (2C), 130.29 (2C), 131.93, 133.70, 135.46, 141.95, 153.57, 180.64 The results obtained in the same manner as described above were obtained. It is shown in Table 1 below.
The respective spectrum data are shown together.
IR(KBr); 3426,1632,1599,1580,1543,1504cm-1 -1 H−NMR(DMSO−d6)δppm; 3.84(s,3H) 6.31(br,1H) 7.08−7.18(m,2H) 7.32(ddd,J=1.02,6.93,8.03Hz,1H) 7.64(ddd,J=1.43,6.93,8.33Hz,1H) 7.68−7.83(m,3H) 8.09(dd,J=1.43,8.03Hz,1H) 11.69(br,1H)13 C−NMR(DMSO−d6); 55.49,106.61,114.51(2C),118.81,123.24,124.79,1
24.90,126.31,129.01(2C),131.78,140.65,149.84,16
1.18,177.02 IR(KBr); 3444,1719,1638,1599,1578,1549,1512cm-1 -1 H−NMR(DMSO−d6)δppm; 1.34(t,J=7.08Hz,3H) 4.35(q,J=7.08Hz,2H) 6.40(d,J=1.46Hz,1H) 7.35(ddd,J=1.17,6.85,8.03Hz,1H) 7.68(ddd,J=1.32,6.85,8.01Hz,1H) 7.78(brd,J=8.01Hz,1H) 7.96−8.14(m,5H) 11.86(br,1H)13 C−NMR(DMSOP−d6); 14.29,61.25,108.13,118.94,123,62,124.88,125.08,1
28.01(2C),129.73(2C),131.49,132.16,138.53,140.
65,148.88,165.31,177.11 IR(KBr); 3464,1636,1601,1557,1510cm-1 1 H−NMR(DMSO−d6)δppm; 6.12(s,2H) 6.32(s,1H) 7.09(d,J=8.05Hz,1H) 7.27−7.42(m,3H) 7.62(ddd,J=1.35,6.87,8.30Hz,1H) 7.75(d,J=8.30Hz,1H) 8.07(dd,J=1.35,8.05Hz,1H)13 C−NMR(DMSO−d6); 101.84,106.68,107.63,108.71,119.11,121,88,123.2
2,124.66,124.78,128.29,131.69,140.86,147.92,149.1
6,149.97,176.69 IR(KBr); 3432,1642,1599,1547,1502cm-1 1 H−NMR(メタノール−d4)δppm; 0.88(t,J=6.32Hz,3H) 1.25−1.41(m,6H) 1.65−1.75(m,2H) 2.68(t,J=7.69Hz,2H) 6.22(s,1H) 7.36(ddd,J=1.39,6.79,8.18Hz,1H) 7.60(brd,J=8.39Hz,1H) 7.71(ddd,J=1.60,6.79,8.39Hz,1H) 8.32(dd,J=1.60,8.18Hz,1H)13 C−NMR(メタノール−d4); 12.48,21.68,28.02,28.25,30.74,33.10,106.92,117.1
8,123.14,123.58,123.79,131.47,139.70,155.22,178.71 IR(ニート); 3380,1638,1603,1557,1514cm-1 1 H−NMR(メタノール−d4)δppm; 1.51−1.83(m,6H) 3.49−3.96(m,2H) 4.52−4.76(m,3H) 6.36(s,1H) 7.30−7.38(m,1H) 7.59−7.64(m,2H) 8.21(d,J=8.24Hz,1H)13 C−NMR(メタノール−d4); 18.33,24.42,29.39,61.48,64.58,98.17,105.96,117.4
2,123.16,123.90,124.02,131.55,139.48,150.46,178.65 IR(KBr); 3472,1630,1597,1562,1512cm-1 1 H−NMR(CDCl3)δppm; 1.46−1.82(m,6H) 1.58(s,6H) 3.41−3.98(m,2H) 4.63(dd,J=2.54,6.50Hz,1H) 6.26(s,1H) 7.20−7.29(m,1H) 7.51(br,1H) 7.52(br,1H) 8.28(d,J=8.06Hz,1H)13 C−NMR(CDCl3); 20.88,24.81,27.18,27.71,32.08,64.62,77.20,95.88,
105.97,117.96,123.34,124.84,125.52,131.71,139.35,1
56.48,178,92 IR(KBr); 3320,1734,1647,1601,1551,1516cm-1 1 H−NMR(CDCl3)δppm; 1.84(s,3H) 2.06−2.10(m,2H) 2.84(t,J=7.81Hz,2H) 4.06(t,J=6.34Hz,2H) 6.26(s,1H) 7.36(dd,J=7.08,7.79Hz,1H) 7.58(ddd,J=1.46,7.08,8.19Hz,1H) 7.77(d,J=7.79Hz,1H) 8.33(dd,J=1.22,8.19Hz,1H) 13.09(br,1H)13 C−NMR(CDCl3); 20.66,27.88,30.66,63.13,107.96,118.63,123.65,12
4.74,124.92,131.86,140.70,154.22,170.87,178.70 IR(KBr); 3298,1729,1647,1599,1545cm-1 1 H−NMR(CDCl3)δppm; 2.06(m,2H) 2.32(t,J=7.84Hz,2H) 2.78(t,J=7.75Hz,2H) 3.56(s,3H) 6.24(s,1H) 7.31(dd,J=7.15,8.14Hz,1H) 7.56(ddd,J=1.28,7.15,8.34Hz,1H) 7.75(brd,J=8.14Hz,1H) 8.31(dd,J=1.28,8.34Hz,1H) 12.77(br,1H)13 C−NMR(CDCl3); 24.08,32.92,33.22,51.58,108.18,118.63, 123.67,124.78,125.04,131.86,140.66,154.18,173.28,1
78.73 IR (KBr); 3426,1632,1599,1580,1543,1504cm -1 -1 H-NMR (DMSO-d 6) δppm; 3.84 (s, 3H) 6.31 (br, 1H) 7.08-7.18 (m, 2H ) 7.32 (ddd, J = 1.02, 6.93, 8.03 Hz, 1H) 7.64 (ddd, J = 1.43, 6.93, 8.33 Hz, 1H) 7.68-7.83 (m, 3H) 8.09 (dd, J = 1.43, 8.03 Hz, 1H) 11.69 (br, 1H) 13 C-NMR (DMSO-d 6); 55.49,106.61,114.51 (2C), 118.81,123.24,124.79,1
24.90,126.31,129.01 (2C), 131.78,140.65,149.84,16
1.18,177.02 IR (KBr); 3444,1719,1638,1599,1578,1549,1512cm -1 -1 H-NMR (DMSO-d 6) δppm; 1.34 (t, J = 7.08Hz, 3H) 4.35 (q, J = 7.08Hz, 2H) 6.40 (d, J = 1.46Hz, 1H) 7.35 (ddd, J = 1.17,6.85,8.03Hz, 1H) 7.68 (ddd, J = 1.32,6.85,8.01Hz, 1H) 7.78 (brd, J = 8.01Hz, 1H) 7.96-8.14 ( m, 5H) 11.86 (br, 1H) 13 C-NMR (DMSOP-d 6); 14.29,61.25,108.13,118.94,123,62,124.88,125.08,1
28.01 (2C), 129.73 (2C), 131.49,132.16,138.53,140.
65,148.88,165.31,177.11 IR (KBr); 3464,1636,1601,1557,1510cm -1 1 H-NMR (DMSO-d 6) δppm; 6.12 (s, 2H) 6.32 (s, 1H) 7.09 (d, J = 8.05Hz, 1H 7.27−7.42 (m, 3H) 7.62 (ddd, J = 1.35,6.87,8.30Hz, 1H) 7.75 (d, J = 1.30Hz, 1H) 8.07 (dd, J = 1.35,8.05Hz, 1H) 13 C -NMR (DMSO-d 6); 101.84,106.68,107.63,108.71,119.11,121,88,123.2
2,124.66,124.78,128.29,131.69,140.86,147.92,149.1
6,149.97,176.69 IR (KBr); 3432,1642,1599,1547,1502cm -1 1 H-NMR ( methanol -d 4) δppm; 0.88 (t , J = 6.32Hz, 3H) 1.25-1.41 (m, 6H) 1.65-1.75 (M, 2H) 2.68 (t, J = 7.69Hz, 2H) 6.22 (s, 1H) 7.36 (ddd, J = 1.39, 6.79, 8.18Hz, 1H) 7.60 (brd, J = 8.39Hz, 1H) 7.71 ( ddd, J = 1.60,6.79,8.39Hz, 1H) 8.32 (dd, J = 1.60,8.18Hz, 1H) 13 C-NMR ( methanol -d 4); 12.48,21.68,28.02,28.25,30.74,33.10,106.92 , 117.1
8,123.14,123.58,123.79,131.47,139.70,155.22,178.71 IR (neat); 3380,1638,1603,1557,1514cm -1 1 H-NMR ( methanol -d 4) δppm; 1.51-1.83 (m , 6H) 3.49-3.96 (m, 2H) 4.52-4.76 (m, 3H) 6.36 (s, 1H) 7.30-7.38 (m, 1H) 7.59-7.64 (m, 2H) 8.21 (d, J = 8.24Hz, 1H) 13 C-NMR ( methanol -d 4); 18.33,24.42, 29.39,61.48,64.58,98.17,105.96,117.4
2,123.16,123.90,124.02,131.55,139.48,150.46,178.65 IR (KBr); 3472,1630,1597,1562,1512cm -1 1 H-NMR (CDCl 3) δppm; 1.46-1.82 (m, 6H) 1.58 (s, 6H) 3.41-3.98 (m, 2H) 4.63 ( dd, J = 2.54, 6.50 Hz, 1H) 6.26 (s, 1H) 7.20-7.29 (m, 1H) 7.51 (br, 1H) 7.52 (br, 1H) 8.28 (d, J = 8.06 Hz, 1H) 13C -NMR (CDCl 3); 20.88,24.81,27.18,27.71,32.08,64.62,77.20,95.88,
105.97,117.96,123.34,124.84,125.52,131.71,139.35,1
56.48,178,92 IR (KBr); 3320,1734,1647,1601,1551,1516cm -1 1 H-NMR (CDCl 3) δppm; 1.84 (s, 3H) 2.06-2.10 (m, 2H) 2.84 (t, J = 7.81Hz , 2H) 4.06 (t, J = 6.34 Hz, 2H) 6.26 (s, 1H) 7.36 (dd, J = 7.08, 7.79 Hz, 1H) 7.58 (ddd, J = 1.46, 7.08, 8.19 Hz, 1H) 7.77 ( d, J = 7.79Hz, 1H) 8.33 (dd, J = 1.22,8.19Hz, 1H) 13.09 (br, 1H) 13 C-NMR (CDCl 3); 20.66,27.88,30.66,63.13,107.96,118.63,123.65 , 12
4.74,124.92,131.86,140.70,154.22,170.87,178.70 IR (KBr); 3298,1729,1647,1599,1545cm -1 1 H-NMR (CDCl 3) δppm; 2.06 (m, 2H) 2.32 (t, J = 7.84Hz, 2H) 2.78 (t, J = 7.75 Hz, 2H) 3.56 (s, 3H) 6.24 (s, 1H) 7.31 (dd, J = 7.15, 8.14Hz, 1H) 7.56 (ddd, J = 1.28, 7.15, 8.34Hz, 1H) 7.75 (brd, J = 8.14 Hz, 1 H) 8.31 (dd, J = 1.28, 8.34 Hz, 1 H) 12.77 (br, 1 H) 13 C-NMR (CDCl 3 ); 24.08, 32.92, 33.22, 51.58, 108.18, 118.63, 123.67, 124.78, 125.04 , 131.86,140.66,154.18,173.28,1
78.73
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI C07D 405/12 215 C07D 405/12 215 // C07B 61/00 300 C07B 61/00 300 ────────────────────────────────────────────────── ─── Continued on the front page (51) Int.Cl. 6 Identification code FI C07D 405/12 215 C07D 405/12 215 // C07B 61/00 300 C07B 61/00 300
Claims (1)
ニル基、シクロアルキル基、水酸基、保護された水酸
基、ニトロ基、ハロゲン原子、シアノ基、アミノ基、エ
ステル基、エステル基の置換した低級アルキル基、炭素
数1〜4個の直鎖もしくは分枝鎖状アルキル基が1〜2
個置換した低級アルキルアミノ基、低級アルコキシ基又
は置換基を有することのある5員もしくは6員の含窒素
複素環基を示し、各R1は相互に異なっていてもよい。X
はハロゲン原子を示す。] で表わされるアニリン誘導体を一般式 CH≡C−R2 [式中、R2は、水素原子、低級アルキル基、低級アルケ
ニル基、シクロアルキル基、水酸基、保護された水酸
基、ニトロ基、ハロゲン原子、シアノ基、アミノ基、エ
ステル基、エステル基の置換した低級アルキル基、炭素
数1〜4個の直鎖もしくは分枝鎖状アルキル基が1〜2
個置換した低級アルキルアミノ基、低級アルコキシ基又
は置換基を有することのある5員もしくは6員環の含窒
素複素環基を示す。] で表されるアセチレン誘導体の存在下パラジウム触媒を
用いた一酸化炭素によってカルボニル化することを特徴
とする一般式 [式中、R1及びR2は、前記に同じ。] で表される4−キノロン誘導体の製造法(1) General formula [Wherein, R 1 is a hydrogen atom, a lower alkyl group, a lower alkenyl group, a cycloalkyl group, a hydroxyl group, a protected hydroxyl group, a nitro group, a halogen atom, a cyano group, an amino group, an ester group, and a substituted ester group. A lower alkyl group, a linear or branched alkyl group having 1 to 4 carbon atoms having 1 to 2 carbon atoms;
It represents an individually substituted lower alkylamino group, lower alkoxy group or 5- or 6-membered nitrogen-containing heterocyclic group which may have a substituent, and each R 1 may be different from each other. X
Represents a halogen atom. Formula CH≡C-R 2 [wherein, R 2 an aniline derivative represented by] a hydrogen atom, a lower alkyl group, lower alkenyl group, a cycloalkyl group, a hydroxyl group, protected hydroxyl group, a nitro group, a halogen atom , A cyano group, an amino group, an ester group, a lower alkyl group substituted with an ester group, a linear or branched alkyl group having 1 to 4 carbon atoms is 1 to 2 or less.
It represents an individually substituted lower alkylamino group, lower alkoxy group or 5- or 6-membered nitrogen-containing heterocyclic group which may have a substituent. Carbonylation with carbon monoxide using a palladium catalyst in the presence of an acetylene derivative represented by the general formula: [Wherein, R 1 and R 2 are the same as above. A method for producing a 4-quinolone derivative represented by the following formula:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2289600A JP2952706B2 (en) | 1990-10-26 | 1990-10-26 | Method for producing 4-quinolone derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2289600A JP2952706B2 (en) | 1990-10-26 | 1990-10-26 | Method for producing 4-quinolone derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH04164070A JPH04164070A (en) | 1992-06-09 |
| JP2952706B2 true JP2952706B2 (en) | 1999-09-27 |
Family
ID=17745337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2289600A Expired - Fee Related JP2952706B2 (en) | 1990-10-26 | 1990-10-26 | Method for producing 4-quinolone derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2952706B2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003035066A1 (en) * | 2001-10-23 | 2003-05-01 | Celltech R & D Limited | 2-aminoquinolone derivatives for use as impdh inhibitors |
| CN110204489B (en) * | 2019-07-09 | 2022-08-02 | 陕西师范大学 | Safe synthesis method of quinolone compounds by using solid carbonyl source |
| WO2023205463A1 (en) | 2022-04-22 | 2023-10-26 | Vertex Pharmaceuticals Incorporated | Heteroaryl compounds for the treatment of pain |
-
1990
- 1990-10-26 JP JP2289600A patent/JP2952706B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH04164070A (en) | 1992-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103052635B (en) | Method for synthesizing benzothiadiazole compounds | |
| EP1529781A1 (en) | A process for the preparation of Imiquimod and intermediates thereof | |
| US20030181759A1 (en) | Process for the preparation of 2-halobenzoic acids | |
| JP4170986B2 (en) | Process for the preparation of phenyl malonate dinitrile | |
| CN112174989A (en) | Preparation method of clitorium | |
| EP3805204A1 (en) | Method for preparing alkynyl pyridine prolyl hydroxylase inhibitor | |
| JP2952706B2 (en) | Method for producing 4-quinolone derivative | |
| KR20220156560A (en) | Synthesis of capsaicin derivatives | |
| CN108794396B (en) | Oxidation method of 4-oxo-2,3-dihydroquinoline compounds | |
| WO2025036129A1 (en) | Method for synthesizing risdiplam intermediate and risdiplam intermediate | |
| CN103702978B (en) | Process for the preparation of 2-amino-5-cyano-N,3-dimethylbenzamide | |
| CN115124460B (en) | Binaphthyl axis chiral ligand containing coordination unit, preparation method and application thereof | |
| JP2952705B2 (en) | Method for producing quinolone carboxylic acid derivative | |
| JP4032220B2 (en) | Alicyclic tetracarboxylic acid compound and process for producing the same | |
| CN109651179B (en) | 2- (2-aminobenzoyl) benzoic acid derivatives and process for preparing the same | |
| JP2011057575A (en) | Manufacturing method of 4-hydroxybenzothiophene derivative | |
| KR100683274B1 (en) | Process for preparing substituted benzopyran compound | |
| CN112694432B (en) | Preparation method of arbidol key intermediate | |
| CN110041334B (en) | A kind of preparation method of aminophenol compound | |
| CN109970616A (en) | A kind of preparation method of N-acylpyrrole derivatives under the catalysis of transition metal ruthenium | |
| JP4288372B2 (en) | Alphapyrones and production method thereof | |
| JP4937442B2 (en) | Process for producing 5-fluorooxindole | |
| CN120794849A (en) | Method for catalyzing coupling reaction of aryl halide and hans ester by photo/cobalt oxidation reduction | |
| CN113896630A (en) | Ring-opening double-iodination reaction method of cyclopropenone and heterocyclic oxygen compound | |
| KR100760015B1 (en) | Intermediates for the synthesis of benzopyran compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |